Investor Relations

2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014
05/10/17
ConforMIS Reports First Quarter 2017 Financial Results
BILLERICA, Mass., May 10, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the first quarter ended March 31, 2017. Q1 Summary: Total revenue of $20.5 million, up 1% year-over-year on a reported basis and up 2% on a constant curre... 

Read more »
04/12/17
ConforMIS Announces Positive Results from Customized iTotal PS Total Knee Replacement Comparative Study
First study of iTotal PS customized implants demonstrated more normal kinematics compared with leading off-the-shelf implants BEDFORD, Mass., April 12, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (Nasdaq:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient's unique anatomy, today announced results from the first study of its iTotal® PS total knee replacement presented at the 2017 British Association for Surgery of the Knee (BASK) Annual Meetin... 

Read more »
04/11/17
ConforMIS to Host First Quarter 2017 Financial Results Conference Call and Webcast on May 10, 2017
BEDFORD, Mass., April 11, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, May 10, 2017, at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter 2017.  To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 5263799. The conference call will be hosted by Mark Augusti, President and Chief Executive Officer, and Paul Weiner, ... 

Read more »
03/31/17
ConforMIS, Inc. Announces Election of Philip W. Johnston to its Board of Directors
BEDFORD, Mass., March 31, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today that its Board of Directors elected Philip W. Johnston to the Board commencing as of the Company’s upcoming Annual Meeting of Stockholders, scheduled for May 8, 2017, and has nominated ... 

Read more »
02/15/17
ConforMIS Reports Fourth Quarter and the Year Ended 2016 Financial Results; Provides 2017 Financial Guidance
BEDFORD, Mass., Feb. 15, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient's unique anatomy, announced today financial results for the fourth quarter and the year ended December 31, 2016. Q4 Summary: Total revenue of $21.7 million, up 14% year-over-year on a reported and constant curre... 

Read more »
01/17/17
ConforMIS to Host Fourth Quarter and Fiscal Year 2016 Financial Results Conference Call and Webcast on February 15, 2017
BEDFORD, Mass., Jan. 17, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, February 15, 2017, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2016.  To participate in the conference call, please call 877-809-6331 (or 615-247-0224 for international) and use conference ID number 55924641. The conference call will be hosted by Mark Augusti, President and C... 

Read more »
01/09/17
ConforMIS Secures Up to $50 Million in Financing from Oxford Finance and Files Shelf Registration Statement
BEDFORD, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- ConforMIS Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells joint replacement implants that are customized to fit each patient's unique anatomy, announced today that the Company has secured up to $50 million in debt financing from Oxford Finance LLC.  ConforMIS also announced today that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission ("SEC"). This debt f... 

Read more »